Literature DB >> 10632297

Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. Centers for Disease Control and Prevention.

.   

Abstract

CDC recommends that all states and territories conduct case surveillance for human immunodeficiency virus (HIV) infection as an extension of current acquired immunodeficiency syndrome (AIDS) surveillance activities. The expansion of national surveillance to include both HIV infection and AIDS cases is a necessary response to the impact of advances in antiretroviral therapy, the implementation of new HIV treatment guidelines, and the increased need for epidemiologic data regarding persons at all stages of HIV disease. Expanded surveillance will provide additional data about HIV-infected populations to enhance local, state, and federal efforts to prevent HIV transmission, improve allocation of resources for treatment services, and assist in evaluating the impact of public health interventions. CDC will provide technical assistance to all state and territorial health departments to continue or establish HIV and AIDS case surveillance systems and to evaluate the performance of their surveillance programs. This report includes a revised case definition for HIV infection in adults and children, recommended program practices, and performance and security standards for conducting HIV/AIDS surveillance by local, state, and territorial health departments. The revised surveillance case definition and associated recommendations become effective January 1, 2000.

Entities:  

Mesh:

Year:  1999        PMID: 10632297

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  65 in total

Review 1.  Public health law reform.

Authors:  L O Gostin
Journal:  Am J Public Health       Date:  2001-09       Impact factor: 9.308

Review 2.  Informational privacy and the public's health: the Model State Public Health Privacy Act.

Authors:  L O Gostin; J G Hodge; R O Valdiserri
Journal:  Am J Public Health       Date:  2001-09       Impact factor: 9.308

3.  Anonymous reporting of HIV infection: an evaluation of the HIV/AIDS surveillance system in Norway 1983-2000.

Authors:  P Aavitsland; O Nilsen; A Lystad
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

4.  Changes in HIV testing after implementation of name-based HIV case surveillance in New Mexico.

Authors:  Amy Lansky; J Stan Lehman; Jill Gatwood; Frederick M Hecht; Patricia L Fleming
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

5.  The Changing Epidemic of HIV.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

6.  Validation of race/ethnicity and transmission mode in the US HIV/AIDS reporting system.

Authors:  Lisa M Lee; J Stan Lehman; Andrew B Bindman; Patricia L Fleming
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

7.  Patients with HIV infection and mental illness: a study of clinical identification.

Authors:  Jae P Douglas; Nancy A Perrin
Journal:  Community Ment Health J       Date:  2003-12

8.  Disparities among US states in HIV-related mortality in persons with HIV infection, 2001-2007.

Authors:  David B Hanna; Richard M Selik; Tian Tang; Stephen J Gange
Journal:  AIDS       Date:  2012-01-02       Impact factor: 4.177

9.  Rapid loss of vaccine-acquired hepatitis B surface antibody after three doses of hepatitis B vaccination in HIV-infected persons.

Authors:  Masako Mizusawa; David C Perlman; David Lucido; Nadim Salomon
Journal:  Int J STD AIDS       Date:  2013-08-29       Impact factor: 1.359

10.  The relationship between type of mental health provider and met and unmet mental health needs in a nationally representative sample of HIV-positive patients.

Authors:  Stephanie L Taylor; M Audrey Burnam; Cathy Sherbourne; Ron Andersen; William E Cunningham
Journal:  J Behav Health Serv Res       Date:  2004 Apr-Jun       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.